GRAND ISLAND, NE - Federal health inspectors identified 10 deficiencies at Good Samaritan Society - Grand Island Village during a standard health inspection completed on December 30, 2025, including a citation for failing to prevent the use of unnecessary psychotropic medications on residents.
[IMAGE]
Unnecessary Psychotropic Medication Use Flagged
Among the deficiencies documented during the inspection, regulators cited the facility under federal tag F0605, which falls under the category of "Freedom from Abuse, Neglect, and Exploitation." Specifically, inspectors determined that Good Samaritan Society - Grand Island Village did not adequately prevent the use of unnecessary psychotropic medications or ensure that medications were not being used in a manner that could restrain a resident's ability to function.
The violation was classified at Scope/Severity Level D, meaning the issue was isolated in nature and no actual harm to residents was documented at the time of the inspection. However, federal regulators determined there was potential for more than minimal harm, a classification that signals genuine concern about resident well-being even when immediate injury has not yet occurred.
Psychotropic medications include a broad class of drugs that affect mood, behavior, and cognitive function. This category encompasses antipsychotics, antidepressants, anti-anxiety medications, and sedatives. While these medications serve legitimate therapeutic purposes when prescribed appropriately, their misuse in nursing home settings has been a persistent concern across the long-term care industry for decades.
The Medical Reality of Chemical Restraint
The use of psychotropic medications as a form of behavioral control rather than as a treatment for a diagnosed medical condition is commonly referred to as chemical restraint. This practice involves administering medication primarily for the convenience of staff or to manage behaviors that could otherwise be addressed through non-pharmacological interventions.
When psychotropic drugs are administered unnecessarily, they can produce a range of adverse effects in elderly residents. Antipsychotic medications, for example, carry an FDA black-box warning indicating an increased risk of death when used in elderly patients with dementia-related psychosis. These medications can cause excessive sedation, cognitive decline, increased fall risk, metabolic changes, and movement disorders such as tardive dyskinesia.
For older adults, the consequences of unnecessary sedation extend beyond the immediate pharmacological effects. A resident who is excessively sedated may be unable to participate in rehabilitation activities, engage socially with other residents, or perform activities of daily living that they would otherwise be capable of completing independently. Over time, this functional decline can become permanent, leading to decreased mobility, muscle wasting, and loss of independence.
Falls represent one of the most significant risks associated with inappropriate psychotropic medication use in nursing homes. Sedating medications impair balance, coordination, and reaction time. For elderly residents who may already have osteoporosis or other conditions that increase fracture risk, a single fall can result in a hip fracture or head injury with life-altering consequences. Research has consistently demonstrated that residents receiving antipsychotic medications experience falls at significantly higher rates than those who do not.
Federal Standards for Psychotropic Medication Use
Under the Nursing Home Reform Act of 1987 and subsequent federal regulations enforced by the Centers for Medicare and Medicaid Services (CMS), nursing facilities are required to ensure that residents are free from unnecessary medications. The regulations specifically state that each resident's drug regimen must be free from unnecessary drugs, defined as any drug used in excessive dose, for excessive duration, without adequate monitoring, without adequate indications for its use, or in the presence of adverse consequences that indicate the dose should be reduced or discontinued.
Federal guidelines mandate that psychotropic medications should only be prescribed when there is a documented clinical indication supported by the resident's medical record. This means a specific diagnosis must be present, the medication must be appropriate for that diagnosis, and non-pharmacological interventions should generally be attempted before resorting to psychotropic drugs.
Furthermore, facilities are required to implement gradual dose reductions for residents receiving psychotropic medications unless clinically contraindicated. This process involves systematically lowering the dose to determine whether the medication remains necessary or whether the resident can function without it. The goal is to use the lowest effective dose for the shortest possible duration.
Proper medication management also requires ongoing monitoring and documentation. Staff must track residents for side effects, assess whether the medication continues to be therapeutically necessary, and document the clinical rationale for continuing or adjusting the prescription. When these monitoring protocols break down, residents may remain on psychotropic medications long after they are medically warranted.
A Pattern Across the Industry
The citation at Good Samaritan Society - Grand Island Village reflects a challenge that extends well beyond any single facility. According to data from CMS, psychotropic medication use in nursing homes has been a focus of federal enforcement efforts for more than a decade. The National Partnership to Improve Dementia Care in Nursing Homes, launched in 2012, specifically targeted the reduction of antipsychotic medication use among nursing home residents.
That initiative produced measurable results nationally, with antipsychotic use rates declining from approximately 24 percent in 2011 to roughly 14 percent by 2023. However, advocacy organizations and federal regulators have noted that progress has plateaued in recent years, and some facilities continue to use these medications at rates that raise questions about appropriateness.
The challenge is particularly acute for residents with dementia and Alzheimer's disease, who may exhibit behavioral symptoms such as agitation, wandering, or verbal outbursts. While these behaviors can be difficult to manage, clinical best practices call for a comprehensive assessment of underlying causes before medication is considered. Pain, environmental stressors, unmet needs, infections, and medication interactions can all produce behavioral symptoms that mimic psychiatric conditions.
Non-pharmacological approaches recommended by clinical guidelines include person-centered care planning, environmental modifications, structured activities, music therapy, and staff training in de-escalation techniques. These interventions address the root causes of behavioral changes rather than simply suppressing symptoms through medication.
Facility Response and Correction Timeline
Good Samaritan Society - Grand Island Village has acknowledged the deficiencies identified during the inspection. The facility's status is listed as "Deficient, Provider has plan of correction," indicating that the facility has submitted a corrective action plan to federal regulators outlining the steps it intends to take to address the cited violations.
According to inspection records, the facility reported that corrections were implemented as of February 6, 2026, approximately five weeks after the inspection date. The specifics of the corrective action plan would typically include measures such as reviewing current psychotropic medication orders, implementing additional staff training on medication management protocols, and establishing enhanced monitoring procedures.
Good Samaritan Society is a national nonprofit organization affiliated with the Evangelical Lutheran Church in America, operating senior care facilities across multiple states. The Grand Island Village location is one of many communities within the organization's network.
What Families Should Know
For families with loved ones residing in nursing facilities, understanding psychotropic medication use is an important aspect of advocating for quality care. Federal law guarantees residents the right to be informed about their medications, including the purpose, potential side effects, and alternatives to any prescribed drug.
Family members can take several practical steps to monitor medication practices:
- Request a complete medication list and ask for an explanation of why each psychotropic medication has been prescribed - Ask whether non-pharmacological interventions were attempted before medication was started - Inquire about gradual dose reduction attempts and whether the facility has evaluated whether the medication remains necessary - Review the resident's behavior and alertness levels during visits, noting any changes that may indicate over-sedation - Attend care plan meetings where medication management should be discussed as part of the resident's overall treatment plan
The full inspection report for Good Samaritan Society - Grand Island Village, including details on all 10 deficiencies cited during the December 2025 inspection, is available through the CMS Care Compare database and on NursingHomeNews.org's facility profile page. Families are encouraged to review the complete findings for a thorough understanding of the facility's regulatory compliance history.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Good Samaritan Society - Grand Island Village from 2025-12-30 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.